Avaí Bio, Inc.
AVAI
$0.33
-$0.02-4.68%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 46.05% | 62.30% | 50.98% | 46.34% | 2.07% |
| Total Depreciation and Amortization | -58.79% | -41.41% | -20.37% | 7.27% | 215.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -121.83% | -107.40% | -139.49% | -112.73% | 5.61% |
| Cash from Operations | -3.31% | 44.46% | -8.86% | 12.22% | 11.88% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | 590.12% | 99.56% | 28.99% | 81.62% | -59.98% |
| Total Debt Repaid | 62.98% | 165.12% | 66.53% | -5.77% | -787.56% |
| Issuance of Common Stock | -68.59% | -73.11% | -11.56% | -18.07% | 11.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -100.00% | -74.00% | -95.67% | -95.67% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 147.50% | -- | -- |
| Cash from Financing | 7.37% | -39.09% | 9.62% | -8.99% | -20.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,050.00% | 29,966.67% | -- | 175.37% | 112.29% |